Innova Medical Group, Inc. delivers better global health outcomes with its deep expertise in testing and unique offerings in diagnostic medical devices and services that help tackle some of the world’s most challenging healthcare problems. INNOVA specializes in innovative screening, testing and diagnostics for cancer, heart disease, arterial calcification, stroke, and virus detection focused on infectious diseases. In response to the global pandemic, INNOVA developed an end-to-end ecosystem of rapid diagnostic and screening tests, along with digital reporting and tracing applications to help organizations manage the COVID-19 crisis. As of March 2021, INNOVA has delivered nearly 1 billion COVID-19 test kits to over 20 countries around the globe, including the United Kingdom, Germany, Finland, Sweden, Austria, Estonia, Israel, Malaysia, and the Sultanate of Oman. As a leader in the research and development of in-vitro diagnostic reagents and test kits, INNOVA has improved lives with testing, monitoring, and implementing medical care. Innova Medical Group is a wholly owned subsidiary of Pasaca Capital, Inc. and is headquartered in Pasadena, CA.